Surveillance guidelines for children with trisomy 13

Research output: Contribution to journalReview articlepeer-review

Abstract

Trisomy 13 is one of the three most common aneuploidy syndromes in live-born infants. It is associated with mortality rates as high as 90% within the first year of life, in large part, due to the high prevalence of severe congenital abnormalities that increase mortality and morbidity. However, life-saving and life-prolonging medical interventions are being performed at a higher rate for these infants, resulting in increased rates of survival. Although cardiac complications have been well described in infants with trisomy 13, these patients also experience other complications such as respiratory, neurological, genitourinary, abdominal, otolaryngologic, and orthopedic complications that can impact their quality of life. The goal of this review is to present a comprehensive description of complications in children with trisomy 13 to aid in the development of monitoring and treatment guidelines for the increasing number of providers who will be caring for these patients throughout their lives. Where the evidence is available, this review presents screening recommendations to allow for more rapid detection and documentation of these complications.

Original languageEnglish (US)
Pages (from-to)1631-1637
Number of pages7
JournalAmerican Journal of Medical Genetics, Part A
Volume185
Issue number5
DOIs
StatePublished - May 2021

Keywords

  • Patau syndrome
  • management
  • screening

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Fingerprint

Dive into the research topics of 'Surveillance guidelines for children with trisomy 13'. Together they form a unique fingerprint.

Cite this